The Bell2Bell (B2B) Podcast

Bell2Bell’s latest podcast features Tony DiMatteo, CEO and co-founder of Lottery.com, a next generation platform where consumers can play the lottery online. Lottery.com recently entered into a definitive agreement to become a publicly listed company through a business combination with special purpose acquisition company, Trident Acquisitions Corp. (NASDAQ: TDAC).

In the briefing, DiMatteo said the company was founded on the belief that lottery players should be able to purchase and manage their tickets online and explained its business model.

Bell2Bell’s latest podcast features Tony DiMatteo, CEO and co-founder of Lottery.com, a next generation platform where consumers can play the lottery online. Lottery.com recently entered into a definitive agreement to become a publicly listed company through a business combination with special purpose acquisition company, Trident Acquisitions Corp. (NASDAQ: TDAC).

In the briefing, DiMatteo said the company was founded on the belief that lottery players should be able to purchase and manage their tickets online and explained its business model.

Bell2Bell’s latest podcast features Ron Loudoun, CEO of Green Hygienics Holdings Inc. (OTCQB: GRYN). Green Hygienics owns the largest single USDA certified organic hemp-for-CBD farm in North America.

During the briefing, Loudoun highlighted last year’s milestones.

“It was a good year establishing ourselves at our new property. When you move into a new property, you have to find out what works best there as far as the pH and the soils and the water and what strain grows best,” he explained. 

Bell2Bell’s latest podcast features Ron Loudoun, CEO of Green Hygienics Holdings Inc. (OTCQB: GRYN). Green Hygienics owns the largest single USDA certified organic hemp-for-CBD farm in North America.

During the briefing, Loudoun highlighted last year’s milestones.

“It was a good year establishing ourselves at our new property. When you move into a new property, you have to find out what works best there as far as the pH and the soils and the water and what strain grows best,” he explained. 

Bell2Bell’s latest podcast features the return of Amir Adnani, President and CEO of Uranium Energy Corp (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects and recently put into place a physical uranium holding initiative.

During the interview, Adnani provided an update on Uranium Energy’s recent news and milestones since his last appearance on The Bell2Bell Podcast, in early February.

Bell2Bell’s latest podcast features the return of Amir Adnani, President and CEO of Uranium Energy Corp (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects and recently put into place a physical uranium holding initiative.

During the interview, Adnani provided an update on Uranium Energy’s recent news and milestones since his last appearance on The Bell2Bell Podcast, in early February.

Bell2Bell’s latest podcast features United Medical Equipment Business Solutions Network Inc. President Jason Pratt and VP of Sales Brian Gartland. In the interview, they explain United Medical Equipment (UME)’s trusted-provider business model.

“Every day 10,000 people turn 65 in the United States. Having a home health background, I saw the need to have trusted resources for seniors and their families,” Pratt said.

Bell2Bell’s latest podcast features United Medical Equipment Business Solutions Network Inc. President Jason Pratt and VP of Sales Brian Gartland. In the interview, they explain United Medical Equipment (UME)’s trusted-provider business model.

“Every day 10,000 people turn 65 in the United States. Having a home health background, I saw the need to have trusted resources for seniors and their families,” Pratt said.

Bell2Bell’s latest podcast features Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).

As discussed in the podcast, XPhyto Therapeutics recently received ISO certification for its rapid point-of-care COVID-19 PCR diagnostic test.

“We expect to be in the market very soon, within 30 days, pending European approval right now,” Rogers said. “Testing is highly relevant and will be for many years to come. The virus is endemic. It appears that it will be a forever problem. It will be active at all times for the foreseeable future somewhere in the world, and testing is a major part of managing that situation. The rollout of vaccines will not be uniform across the globe. There will be significant discrepancies, primarily for logistical and economic reasons, between the developing world and the developed world. Any time there’s international travel, and in particular between jurisdictions with disparity of economic comfort or success, there’s going to be this need for ongoing testing.”

Bell2Bell’s latest podcast features Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).

As discussed in the podcast, XPhyto Therapeutics recently received ISO certification for its rapid point-of-care COVID-19 PCR diagnostic test.

“We expect to be in the market very soon, within 30 days, pending European approval right now,” Rogers said. “Testing is highly relevant and will be for many years to come. The virus is endemic. It appears that it will be a forever problem. It will be active at all times for the foreseeable future somewhere in the world, and testing is a major part of managing that situation. The rollout of vaccines will not be uniform across the globe. There will be significant discrepancies, primarily for logistical and economic reasons, between the developing world and the developed world. Any time there’s international travel, and in particular between jurisdictions with disparity of economic comfort or success, there’s going to be this need for ongoing testing.”